Psoriasis exacerbation after hormonotherapy in prostate cancer patient-Case report

Reports of Practical Oncology and Radiotherapy

Volumn 15, Issue 4, 2010, Pages 103-106

  Ziółkowska, Ewa ^a   Biedka, Marta ^a,b   Zyromska, Agnieszka ^b,c   Makarewicz, Roman ^b,c  

^a Regional Oncology Centre Bydgoszcz   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^c Oncology Centre in Bydgoszcz   (Poland)

Author keywords

Hormonotherapy; Prostate cancer; Psoriasis

Indexed keywords

CORTICOSTEROID; FLUTAMIDE; TRIPTORELIN;

ADULT; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER HORMONE THERAPY; CANCER PATIENT; CASE REPORT; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DRUG ERUPTION; ERYTHEMA; HOSPITAL ADMISSION; HUMAN; MALE; PROSTATE ADENOCARCINOMA; PSORIASIS; SKIN EXFOLIATION; SKIN PRURITUS;

EID: 77955841438     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rpor.2010.03.003     Document Type: Article

References (18)

1. Linden K., Weinstein G. Psoriasis: current perspectives with an emphasis on treatment. Am J Med 1999, 107:595-605.
2. Naldi L., Gambini D. The clinical spectrum of psoriasis. Clin Dermatol 2007, 25:58.
3. Gottlieb A. Psoriasis. DMCO 1998, 1:195-202.
4. de Jong E. The course of psoriasis. Clin Dermatol 1997, 15:687-692.
5. Ben-Yosef R., Soyfer V., Vexler A. Radiation therapy in cancer patients with psoriasis. The fractionated daily dose and the Koebner phenomenon. Radiother Oncol 2005, 74:21-23.
6. Charalambous H., Bloomfield D. Psoriasis and radiotherapy: exacerbation of psoriasis following radiotherapy for carcinoma of the breast (the Koebner phenomenon). Clin Oncol 2000, 12:192-193.
7. Tsankov N., Kazandjieva J., Drenovska K. Drugs in exacerbation and provocat of psoriasis. Clin Dermatol 1998, 16:333-351.
8. Chao C. Practical essentials of intensity modulated radiation therapy, 2nd ed. Lippincott Williams and Wilkins. p. 311-20, Pub date: September 2004.
9. Shah M., Maibach H. Estrogen and skin. An overview. Am J Clin Dermatol 2001, 2:143-150.
10. Gilliver S., Wu F., Ashcroft G. Regulatory roles of androgens in cutaneous wound healing. Thromb Haemost 2003, 90:978-985.
11. Mowad C., Margolis D., Halpern A., Suri B., Synnestvedt M., Guzzo C. Hormonal influences on women with psoriasis. Cutis 1998, 61:257-260.
12. Swanbeck G., Inerot A., Martinsson T., Wahlstrom J. A population genetic study of psoriasis. Br J Dermatol 1994, 131:32-39.
13. Damasiewicz-Bodzek A., Kos-Kudła B. Rola hormonów w etiopatogenezie łuszczycy. Pol Merk Lek 2007, 127:75-78.
14. Holzmann H., Benes P., Morsches B. Dehydroepiandrosternmagel bei psoriasis. Hautarzt 1980, 31:71-78.
15. Schwarz W., Schnell H., Honstein O., et al. Testosterone serum levels in male psoriatics. Arch Dermatol Res 1981, 270:377-379.
16. Schreiber G.J., Muller-Runkel R. Exacerbation of psoriasis after megavoltage irradiation. Cancer 1991, 67:588-589.
17. Tomlinson M. Psoriasis and radiotherapy. Clin Oncol 2001, 13:145-146.
18. Charalambous H., Bloomfield D. Psoriasis and radiotherapy: exacerbation of psoriasis following radiotherapy for carcinoma of the breast (Koebner Phenomenon). Clin Oncol 2000, 12:192-193.